Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease
about
Omega-3 fatty acids: potential role in the management of early Alzheimer's diseaseNeuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivoIsoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseasesExpression and activities of aldo-keto oxidoreductases in Alzheimer diseaseNeurofurans, novel indices of oxidant stress derived from docosahexaenoic acidAssociation of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.Biomarkers for cognitive impairment and dementia in elderly people.Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice.Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity.The isoprostanes--25 years laterOmega-3 fatty acids and dementia.Omega-3 fatty acids and cognitive function in women.Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.Why pleiotropic interventions are needed for Alzheimer's disease.Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity.Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegenerationIncreased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer diseaseCerebrospinal fluid biomarkers in mild cognitive impairment and dementiaOxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.Oxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories.Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry.Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?Oxidative balance score and oxidative stress biomarkers in a study of Whites, African Americans, and African immigrants.Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain.Isoprostane generation and function.The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brainBiomarkers of lipid peroxidation in Alzheimer disease (AD): an update.Antioxidants for the treatment of mild cognitive impairment.Gene-environment interplay in neurogenesis and neurodegeneration.Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics.The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation.F2-isoprostanes as markers of oxidative stress in vivo: an overview.NADPH:quinone oxidoreductase 1 regulates host susceptibility to ozone via isoprostane generation.Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,N-diethyldithiocarbamate peripheral myelinopathy.Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain.Electrophilic cyclopentenone isoprostanes in neurodegeneration.F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease.Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease.
P2860
Q24595490-7B102682-E7BA-4A0B-8850-DA763C0B3C6CQ24793951-A28D7C46-8566-4E71-AEF1-6587A86C3E4DQ26822872-6AAC059C-431A-49DC-A560-D0A6B5097A65Q28205423-5A2CC232-CD27-43A7-BCFD-81E4E543E158Q28252451-BE1DCED5-6F65-41F1-BDE7-07857FCF36BCQ30238885-2DE2EF53-1D0B-40A0-885B-694C502BB633Q30370745-62EF909A-9278-4C52-B6F0-A1E594962F42Q30505920-5E3C6EFF-2B30-4B5A-9F1C-DAEEE873F0B5Q33214473-75F677CB-3300-4E81-A9A1-49DB22384768Q33601352-7FCBCB7F-9658-462A-A972-77B7AF02D84DQ33602402-E91BEAEB-CA2D-424A-9DF1-CBAB138EDBCBQ33677382-01C95D3F-C3E8-45DC-85CF-D09FBF92B766Q33688993-6065BDB7-237C-4583-811B-B1BEF9565066Q33876128-AC55B5D8-FF62-4B91-8E9B-F7B8A4CE4301Q33896920-7FAAA78E-7A1D-4F2C-9D0A-1073E2D9BC87Q33896926-16E77631-4FEC-483D-AA06-66DC69B1E4C5Q33897525-A14283BC-4443-44E3-89EB-C4986E795031Q33936708-9C049D7A-2FC3-4C51-9DFA-B5929A0F349DQ34258737-EB1DAFDF-41AC-4CDF-937E-9D95F9E3349AQ34561160-B37C3346-7EA4-4675-940D-7C83E2394618Q35012725-1EC15D5F-CEBB-4634-A05C-1FE30E4C7448Q35047134-1D1D180A-12B7-4BFA-BA63-C960084AB90AQ35198505-29325E48-DF9E-4062-BF46-A065838B0A13Q35286714-C2F836C5-D7E9-410E-88DB-A278F54DCDA8Q35332267-896DE71C-27FC-4745-855B-E5B94198E0AEQ35690918-278E9A1F-B6D4-49DE-AA7A-66E8DD23E8A4Q35738877-0B5B3FF1-8791-414B-9D8B-6555AE35DEB0Q35841741-7169117F-2E0F-4F5B-957F-7D686A5EB5B5Q36003798-3D7C77E6-C313-4E1C-84C7-D73D4DDA2DC6Q36026546-A83F3FFF-FE58-4F62-857F-721878C4DFD9Q36099067-3F70F16E-EC6F-4B61-87DC-9147038C4619Q36137005-A192D1A7-5CBB-4640-9B53-AB4B047EB115Q36317981-AD519F54-3320-4171-AEA5-0E461AFAEBEBQ36620730-348E3A8D-28CE-46E9-B841-5B89A31EB722Q36688749-DD3FB083-8B03-44A7-A3C8-4DE5BD06D083Q36724235-E73EFBFA-3EFF-428C-BD35-168EE134D818Q36836025-D9EA1854-F936-473D-8152-A15F0DBE7E24Q36954194-986694F4-5E8C-4D6F-81CA-9119B1ACBCA2Q36954208-C7771463-D63B-4967-8F5F-ECAA9117C9A0Q37024930-39102C72-32CD-4054-8E9A-D6E5B7DDDEAA
P2860
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Brain regional quantification ...... ostanes in Alzheimer's disease
@ast
Brain regional quantification ...... ostanes in Alzheimer's disease
@en
Brain regional quantification ...... ostanes in Alzheimer's disease
@nl
type
label
Brain regional quantification ...... ostanes in Alzheimer's disease
@ast
Brain regional quantification ...... ostanes in Alzheimer's disease
@en
Brain regional quantification ...... ostanes in Alzheimer's disease
@nl
prefLabel
Brain regional quantification ...... ostanes in Alzheimer's disease
@ast
Brain regional quantification ...... ostanes in Alzheimer's disease
@en
Brain regional quantification ...... ostanes in Alzheimer's disease
@nl
P2093
P2860
P1476
Brain regional quantification ...... ostanes in Alzheimer's disease
@en
P2093
J D Morrow
L J Roberts
T J Montine
W R Markesbery
P2860
P356
10.1016/S0002-9440(10)63968-5
P407
P577
2001-01-01T00:00:00Z